Drug Shortage Report for RYALTRIS

Last updated on 2023-11-25 History
Report ID 201860
Drug Identification Number 02531186
Brand name RYALTRIS
Common or Proper name Olopatadine Hydrochloride and Mometasone Furoate Monohydrate Spray
Company Name GLENMARK SPECIALTY SA
Market Status MARKETED
Active Ingredient(s) MOMETASONE FUROATE
Strength(s) 25MCG 665MCG
Dosage form(s) SPRAY, METERED DOSE
Route of administration NASAL
Packaging size 240 MD 1 carton
ATC code R01AD
ATC description DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2023-08-15
Actual start date 2023-08-15
Estimated end date 2023-11-27
Actual end date 2023-11-24
Shortage status Resolved
Updated date 2023-11-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address PLACE DU PORT 2
NEUCHÂTEL, --
SWITZERLAND 2000
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2023-11-25 English Compare
v9 2023-11-24 French Compare
v8 2023-11-24 English Compare
v7 2023-11-08 French Compare
v6 2023-11-08 English Compare
v5 2023-10-05 French Compare
v4 2023-10-05 English Compare
v3 2023-08-16 English Compare
v2 2023-08-15 French Compare
v1 2023-08-15 English Compare

Showing 1 to 10 of 10